European Journal of Rheumatology
Case Report

Thrombocytopenia caused by albendazole in a patient with Sjögren’s syndrome: A case report


Department of Internal Medicine, Gaziantep University Faculty of Medicine, Gaziantep, Turkey


Department of Internal Medicine, Adıyaman University Faculty of Medicine, Adıyaman, Turkey


Department of Rheumatology, School of Medicine, University of Uludağ, Bursa, Turkey

Eur J Rheumatol 2014; 1: 44-45
DOI: 10.5152/eurjrheum.2014.009
Read: 1408 Downloads: 1324 Published: 03 September 2019


Sjögren’s syndrome (SS) is an autoimmune disease characterised by a chronic inflammatory response mainly localised to the lachrymal and salivary glands. Haematological abnormalities are common, although they rarely have clinical significance. Here, we report a patient with SS and thrombocytopenia caused by albendazole. Haematological abnormalities such as thrombocytopenia are seen in approximately 5-15% of SS patients; however, this disease is usually asymptomatic and can often be recovered to normal levels with corticosteroids. If it is not, we should keep in mind other reasons for the thrombocytopenia, such as drug use. 


EISSN 2148-4279